Family Medicine, Adult Medicine · Flushing, NY
NPI
1659536233
Since 2008
Specialty
Family Medicine, Adult Medicine
Code 207QA0505X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
136-68 Roosevelt Ave, Ste 2a2b
Flushing, NY, 11354
Phone (347) 827-9251
Groups this clinician bills Medicare through
Medicare paid, 2024
$29K
537 services
Medicare patients, 2024
58
Average age 75
Drug cost, 2024
$6.4M
45,758 prescriptions
Company payments, 2025
$3,644
From 24 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Yuqing Zhang was code 99213 (office e&m - established), 199 times for 51 patients. In total Yuqing Zhang billed 537 services in 24 codes, and Medicare paid $29K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-08-14.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 199 | 51 | $68.05 | $14K |
| 99212 Office E&M - Established | Office | 42 | 26 | $42.85 | $1,800 |
| 36415 Venipuncture Blood Collection | Office | 31 | 27 | $8.60 | $267 |
| 99497 Care Management/Coordination | Office | 27 | 26 | $72.42 | $1,955 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 21 | 21 | $144.62 | $3,037 |
| G0008 Administration of influenza virus vaccine | Office | 17 | 17 | $35.18 | $598 |
| 90661 Vaccine Product | Office | 15 | 15 | $36.11 | $542 |
| 93000 Electrocardiogram | Office | 12 | 12 | $7.57 | $90.86 |
By year: 2022 $48K for 6,857 services; 2023 $39K for 3,656 services; 2024 $29K for 537 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 31 | 27 | $8.60 | $267 |
Medicare prescription drug claims, 2024
In 2024, the drug Yuqing Zhang prescribed most often to Medicare patients was Vascepa (Icosapent Ethyl), with 2,978 prescriptions and refills. In total Yuqing Zhang wrote 45,758 Medicare prescriptions that cost $6.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Vascepa Icosapent Ethyl | 2,978 | 3,120 | 416 | $1.1M |
| Atorvastatin Calcium Generic | 1,875 | 2,284 | 283 | $9,223 |
| Metoprolol Succinate Generic | 1,543 | 1,802 | 208 | $11K |
| Rosuvastatin Calcium Generic | 1,452 | 1,716 | 187 | $7,703 |
| Esomeprazole Magnesium Generic | 1,307 | 1,395 | 182 | $15K |
| Janumet Sitagliptin Phos/Metformin Hcl | 1,269 | 1,395 | 172 | $741K |
| Diclofenac Epolamine Generic | 1,258 | 1,329 | 223 | $658K |
| Losartan Potassium Generic | 1,220 | 1,454 | 185 | $6,923 |
| Tamsulosin Hcl Generic | 1,073 | 1,259 | 137 | $6,767 |
| Amlodipine Besylate Generic | 1,050 | 1,253 | 135 | $4,833 |
| Jardiance Empagliflozin | 1,045 | 1,132 | 135 | $659K |
| Donepezil Hcl Generic | 903 | 1,009 | 142 | $5,837 |
| Omeprazole Generic | 902 | 967 | 171 | $5,767 |
| Chlorhexidine Gluconate Generic | 871 | 871 | 301 | $3,594 |
| Amlodipine-Valsartan Amlodipine Besylate/Valsartan | 753 | 846 | 107 | $14K |
Brand drugs: 11,754 claims; generic drugs: 32,599 claims; opioid claims: 15.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Yuqing Zhang $3,644 ($3,644 in general payments such as food, travel and fees) from 24 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $427.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 18 | $427 |
| Amgen Inc. AMGN | 13 | $375 |
| Abbvie Inc. ABBV | 24 | $348 |
| GlaxoSmithKline, LLC. GSK | 15 | $301 |
| Eisai Inc. 4523.T | 5 | $214 |
| Phathom Pharmaceuticals, Inc. PHAT | 4 | $207 |
| Kowa Pharmaceuticals America, Inc. | 17 | $205 |
| Medtronic, Inc. MDT | 2 | $160 |
| Incyte Corporation INCY | 7 | $151 |
| Cordis US Corp. JNJ | 1 | $145 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.